Determinants of Ceftazidime Clearance by Continuous Venovenous Hemofiltration and Continuous Venovenous Hemodialysis

Although several dosage adjustment regimens have been proposed, there is little quantitative information to guide the initiation of ceftazidime therapy in patients who are receiving continuous renal replacement therapy. To determine the clearance of ceftazidime by continuous venovenous hemofiltratio...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Matzke, Gary R., Frye, Reginald F., Joy, Melanie S., Palevsky, Paul M.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2000
Assuntos:	Pharmacology
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89925/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10817721/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.6.1639-1644.2000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!